ArticleEBioMedicine2019

Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.

Ching-Lung Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.